The expression of PTPRM was low in patients with EOC, and the positive rate of PTPRM expression significantly decreased with progressing stages of EOC and tumor recurrence, suggesting the role of PTPRM as a tumor suppressor in the progression of EOC. Here, PTPRM is linked to neoplasm.